Group One Trading’s Pacira BioSciences PCRX Stock Holding History

Group One Trading’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$7.46K	–	8485
2025 Q1	$7.46K	Sell	300 -7,700	-96%	-$184K	﹤0.01%	6438
2024 Q4	$151K	Sell	8,000 -9,800	-55%	-$172K	﹤0.01%	4164
2024 Q3	$268K	Buy	17,800 +8,600	+93%	+$147K	﹤0.01%	3359
2024 Q2	$263K	Hold	9,200	–	–	﹤0.01%	3165
2024 Q1	$269K	Hold	9,200	–	–	﹤0.01%	3305
2023 Q4	$310K	Hold	9,200	–	–	﹤0.01%	3481
2023 Q3	$282K	Hold	9,200	–	–	﹤0.01%	3495
2023 Q2	$369K	Buy	+9,200	New	+$380K	﹤0.01%	3334
2022 Q4	–	Sell	-500	Closed	-$27K	–	7885
2022 Q3	$27K	Sell	500 -500	-50%	-$27.8K	﹤0.01%	5882
2022 Q2	$58K	Sell	1,000 -29,000	-97%	-$1.9M	﹤0.01%	5439
2022 Q1	$2.29M	Buy	+30,000	New	+$2M	﹤0.01%	2267
2021 Q2	–	Sell	-9,000	Closed	-$631K	–	8465
2021 Q1	$631K	Buy	9,000 +2,500	+38%	+$179K	﹤0.01%	3761
2020 Q4	$389K	Hold	6,500	–	–	﹤0.01%	3500
2020 Q3	$391K	Buy	+6,500	New	+$378K	﹤0.01%	3065
2020 Q1	–	Sell	-1,600	Closed	-$72K	–	5620
2019 Q4	$72K	Sell	1,600 -1,100	-41%	-$46.7K	﹤0.01%	3831
2019 Q3	$103K	Hold	2,700	–	–	﹤0.01%	3535
2019 Q2	$117K	Buy	2,700 +2,600	+2,600%	+$110K	﹤0.01%	3234
2019 Q1	$4K	Sell	100 -11,600	-99%	-$453K	﹤0.01%	4482
2018 Q4	$503K	Sell	11,700 -18,700	-62%	-$873K	﹤0.01%	1980
2018 Q3	$1.49M	Sell	30,400 -10,200	-25%	-$441K	0.01%	1382
2018 Q2	$1.3M	Buy	40,600 +4,900	+14%	+$169K	0.01%	1463
2018 Q1	$1.11M	Sell	35,700 -46,900	-57%	-$1.67M	0.01%	1442
2017 Q4	$3.77M	Buy	82,600 +70,000	+556%	+$2.77M	0.03%	797
2017 Q3	$473K	Sell	12,600 -10,100	-44%	-$406K	﹤0.01%	2111
2017 Q2	$1.08M	Buy	22,700 +15,700	+224%	+$728K	0.01%	1395
2017 Q1	$319K	Buy	7,000 +2,300	+49%	+$99.4K	﹤0.01%	2184
2016 Q4	$152K	Sell	4,700 -15,000	-76%	-$501K	﹤0.01%	2596
2016 Q3	$674K	Buy	19,700 +14,100	+252%	+$552K	0.01%	1582
2016 Q2	$189K	Sell	5,600 -12,200	-69%	-$600K	﹤0.01%	2436
2016 Q1	$943K	Sell	17,800 -8,100	-31%	-$474K	0.01%	1211
2015 Q4	$1.99M	Buy	25,900 +9,300	+56%	+$527K	0.02%	858
2015 Q3	$682K	Sell	16,600 -6,900	-29%	-$423K	0.01%	1535
2015 Q2	$1.66M	Sell	23,500 -9,100	-28%	-$717K	0.02%	861
2015 Q1	$2.9M	Buy	32,600 +21,000	+181%	+$2.13M	0.05%	464
2014 Q4	$1.03M	Sell	11,600 -16,600	-59%	-$1.57M	0.02%	1061
2014 Q3	$2.73M	Buy	28,200 +11,600	+70%	+$1.13M	0.04%	536
2014 Q2	$1.52M	Sell	16,600 -10,100	-38%	-$769K	0.02%	863
2014 Q1	$1.87M	Buy	26,700 +8,000	+43%	+$544K	0.03%	656
2013 Q4	$1.07M	Sell	18,700 -1,400	-7%	-$73.6K	0.02%	1057
2013 Q3	$966K	Sell	20,100 -1,900	-9%	-$69.2K	0.02%	1051
2013 Q2	$638K	Buy	+22,000	New	+$636K	0.02%	1150

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's PCRX Position: Q3 2025 in Review

Group One Trading sold out of Pacira BioSciences (PCRX) in Q3 2025, closing a stake of 357 shares — an estimated $8.77K sold.

Group One Trading first reported a position in PCRX in Q2 2013 and held it in 28 quarters. The position peaked at $1.39M in Q1 2015. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2025.

Group One Trading reported no remaining Pacira BioSciences position as of Q3 2025 after selling out during the quarter.
Group One Trading sold 357 Pacira BioSciences shares in Q3 2025, an estimated $8.77K.
Group One Trading first reported a position in Pacira BioSciences in Q2 2013 and held it in 28 quarters.
Group One Trading's Pacira BioSciences position peaked at $1.39M in Q1 2015.
239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.